Literature DB >> 24685733

Prevalence of chronic kidney disease and its contributing risk factors in southern Iran: a cross-sectional adult population-based study.

Parviz Khajehdehi, Leila Malekmakan1, Maryam Pakfetrat, Jamshid Roozbeh, Mehrab Sayadi.   

Abstract

INTRODUCTION: The global prevalence of chronic kidney disease (CKD) is increasing consistently. Progression of CKD to end-stage renal disease could be slowed down by early detection and treatment, yet CKD and its risk factors have been poorly studied in many countries. This study investigated the CKD prevalence and its contributing risk factors in adult population of Southern Iran.
MATERIALS AND METHODS: In this cross-sectional study on randomly recruited participants from adult population, we investigated the CKD prevalence (stages 3 to 5) and its risk factors in Southern Iran. After calculation of sample size (10385 cases), data was collected in a total of 10397 individuals. Medical and demographic data was obtained, as well as measurement of height, body weight, blood pressure, and blood urea nitrogen, and serum creatinine. A fresh spot urinalysis was also performed.
RESULTS: The overall prevalence of CKD stages 3 to 5 was 11.6%. Stages 1, 2, 3, 4, and 5 of CKD were found in 8.5%, 66.1%, 11.4%, 0.1%, and 0.1% of the participants, respectively. The prevalence of CKD (stages 3 to 5) was significantly higher compared to those with the non-CKD group, in the older than younger participants, and in the women as compared to the men. There was a strong positive correlation between age, female sex, hypertension, and high body mass index with different stages of CKD.
CONCLUSIONS: The prevalence of CKD is high in Southern Iran and its contributing risk factors are older age, female sex, hypertension, and high body mass index.

Entities:  

Mesh:

Year:  2014        PMID: 24685733

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  16 in total

1.  Dietary total antioxidant capacity and incidence of chronic kidney disease in subjects with dysglycemia: Tehran Lipid and Glucose Study.

Authors:  Golaleh Asghari; Emad Yuzbashian; Sahar Shahemi; Zahra Gaeini; Parvin Mirmiran; Fereidoun Azizi
Journal:  Eur J Nutr       Date:  2017-07-24       Impact factor: 5.614

2.  Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study.

Authors:  Minzhen Wang; Miao Xia; Hongyan Yang; Desheng Zhang; Yanan Zhao; Yingqian He; Jing Liu; Lulu Zhang; Chun Yin; Yana Bai
Journal:  Endocrine       Date:  2022-07-02       Impact factor: 3.925

3.  Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.

Authors:  Samira Arbabi Jam; Behrooz Moloudpour; Farid Najafi; Mitra Darbandi; Yahya Pasdar
Journal:  BMC Nephrol       Date:  2022-07-01       Impact factor: 2.585

4.  Chronic kidney disease in low- and middle-income countries.

Authors:  John W Stanifer; Anthony Muiru; Tazeen H Jafar; Uptal D Patel
Journal:  Nephrol Dial Transplant       Date:  2016-02-04       Impact factor: 5.992

5.  Prevalence of impaired renal function and determinants in the southwest of Iran.

Authors:  Saba Alvand; Farhad Abolnezhadian; Sudabeh Alatab; Zahra Mohammadi; Fatemeh Hayati; Mohammad Noori; Leila Danehchin; Yousef Paridar; Bahman Cheraghian; Zahra Rahimi; Sanam Hariri; Sahar Masoudi; Seyed Ali Mard; Ali Akbar Shayesteh; Hossein Poustchi
Journal:  BMC Nephrol       Date:  2021-08-10       Impact factor: 2.388

6.  Micronutrient Intakes and Incidence of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study.

Authors:  Hossein Farhadnejad; Golaleh Asghari; Parvin Mirmiran; Emad Yuzbashian; Fereidoun Azizi
Journal:  Nutrients       Date:  2016-04-20       Impact factor: 5.717

Review 7.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

Review 8.  Sleep Quality in Iranian Hemodialysis Patients: A Systematic Review and Meta-analysis.

Authors:  Masood Taheri Mirghaed; Razieh Sepehrian; Amir Rakhshan; HasanAbolghasem Gorji
Journal:  Iran J Nurs Midwifery Res       Date:  2019-11-07

9.  Effectiveness and safety profiling of zolpidem and acupressure in CKD associated pruritus: An interventional study.

Authors:  Inayat Ur Rehman; Raheel Ahmed; Aziz Ur Rahman; David Bin Chia Wu; Syed Munib; Yasar Shah; Nisar Ahmad Khan; Ateeq Ur Rehman; Learn Han Lee; Kok Gan Chan; Tahir Mehmood Khan
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.889

10.  A randomized controlled trial for effectiveness of zolpidem versus acupressure on sleep in hemodialysis patients having chronic kidney disease-associated pruritus.

Authors:  Inayat Ur Rehman; David Bin-Chia Wu; Raheel Ahmed; Nisar Ahmad Khan; Aziz Ur Rahman; Syed Munib; Learn Han Lee; Kok Gan Chan; Tahir Mehmood Khan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.